Prognostic Impact of the ABCC11/MRP8 Polymorphism in Adjuvant Oral Chemotherapy with S-1 for Non-Small Cell Lung Cancer.
Tsuchiya T, Arai J, Matsumoto K, Miyazaki T, Honda S, Tagawa T, Nakamura A, Taniguchi H, Sano I, Akamine S, Muraoka M, Hisano H, Yamasaki N, Nagayasu T.
Tsuchiya T, et al. Among authors: honda s.
Chemotherapy. 2016;61(2):77-86. doi: 10.1159/000438942. Epub 2015 Nov 26.
Chemotherapy. 2016.
PMID: 26606244
Clinical Trial.